Medical metaverse company cleared for MR surgical planning platform
Summary
apoQlar will extend its distribution of VSI HoloMedicine in the USA for clinical use through its subsidiary in Miami, Florida, with availability expected in the second quarter of 2023. Following this major achievement, apoQlar is now raising a Series A round, its first ever fundraising campaign, to scale VSI Holomedicine as the foundation of modern surgical care. We can leverage digital objects and services on top of the real world for equal or greater utility and usually at a fraction of the cost. Mixed Reality is a completely new way for people, and in our case surgeons, physicians and technologists, to continue to experience the real world around them but with an entire virtual layer placed on top" says Sirko Pelzl, Co-Founder & CEO of apoQlar. We are a young company, but this serves as a true testament of our collective team mindset and diligence" says Liliana Duarte, COO of apoQlar.